RxDoctor Payments Data

Henry Rodriguez Ginorio, MD

Gynecology · San Juan, PRNPI 1366427833

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,750 of the $9,305 with a category attached, or 83.3%. AbbVie accounts for 71.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $5,575 and has fallen 97.9% since, to $119 in 2025. Among gynecology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,305in general payments, 2019–2025

Across 33 payments — averaging $281.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$7K
  • Merck$2K
  • BD$269
  • Davol Inc.$120
  • Medtronic$100
  • Roche Diagnostics Corporation$92
  • plus $147 from 4 others
$495,461in research payments, 2019–2025

Across 227 payments — averaging $2182.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$425K
  • Merck$71K

What the payments were for

  • Consulting fees$7,75083%
  • Food & beverage$1,53516%
  • Gifts$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie11$6,621
Merck7$1,955
BD5$269
Davol Inc.1$120
Medtronic1$100
Roche Diagnostics Corporation1$92
Hologic Sales And Service, LLC3$75
PBG Puerto Rico LLC2$35
Ascend Therapeutics US, LLC1$20
Pfizer Pharmaceuticals LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,305 in reported general payments places this provider in the 95th percentile of 50 gynecology providers in Puerto Rico.

See all gynecology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$25,336
Medicare patients
125
Services billed
307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol (Once Weekly)Estradiol56$4,213
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip105$3,301
ProgesteroneProgesterone, Micronized32$1,652
Terconazole42$1,374
Estradiol18$1,157
Clobetasol Propionate27$1,021
ClimaraEstradiol12$934
Clindamycin Phosphate12$931
YuvafemEstradiol13$753

Paid to pharmacies, not to this prescriber.

Other gynecology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →